Sarepta Therapeutics, Inc. (SRPT): Cash & Equivalents
$801.28M
As of 2025-12-31
$571.15M
As of 2026-06-30
-6.1%
3-year compound annual growth
-11.8%
5-year compound annual growth
+25.9%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $801.28M | -27.4% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $1.10B | +157.5% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $428.43M | -55.7% | 2026-03-02, Balance as of period end |
| 2022-12-31 | $966.78M | -54.3% | 2025-02-28, Balance as of period end |
| 2021-12-31 | $2.12B | +40.8% | 2024-02-28, Balance as of period end |
| 2020-12-31 | $1.50B | +79.9% | 2023-02-28, Balance as of period end |
| 2019-12-31 | $835.08M | +125.2% | 2022-03-01, Balance as of period end |
| 2018-12-31 | $370.83M | -38.2% | 2021-03-01, Balance as of period end |
| 2017-12-31 | $599.69M | +389.9% | 2020-02-26, Balance as of period end |
| 2016-12-31 | $122.42M | +52.4% | 2019-02-28, Balance as of period end |
| 2015-12-31 | $80.30M | +9.2% | 2017-02-28, Balance as of period end |
| 2014-12-31 | $73.55M | -71.4% | 2017-02-28, Balance as of period end |
| 2013-12-31 | $256.96M | +36.9% | 2016-02-25, Balance as of period end |
| 2012-12-31 | $187.66M | +370.3% | 2015-02-26, Balance as of period end |
| 2011-12-31 | $39.90M | +18.8% | 2014-03-03, Balance as of period end |
| 2010-12-31 | $33.59M | -30.4% | 2014-03-03, Balance as of period end |
| 2009-12-31 | $48.27M | +331.3% | 2013-03-15, Balance as of period end |
| 2008-12-31 | $11.19M | n/a | 2012-03-13, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $801.28M | -27.4% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $618.70M | -33.4% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $984.65M | +26.3% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $282.03M | +155.1% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.56B | -8.3% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $61.42M | -9.7% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $1.31B | +39.1% |
| Alkermes plc. (ALKS) | 2025-12-31 | $388.57M | +33.5% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $1.66B | +71.5% |
Compare SRPT, RPRX, PTCT, AMRX side by side · Screen every company in Pharmaceutical Preparations ↗